[1]Ji P, Diederichs S, Wang W, et al. MALAT1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in earlystage nonsmall cell lung cancer\[J\]. Oncogene, 2003, 22(39):8031-8041.
[2]Hu X, Bao J, Zhen W, et al. The plasma lncRNA acting as fingerprint in nonsmallcell lung cancer\[J\]. Tumor Biol, 2016, 37(3):3497-3504.
[3]Tarro G, Perna A, Esposito C. Early diagnosis of lung cancer by detection of tumor liberated protein\[J\]. J Cell Physiol, 2005, 203(1):1-5.
[4]Fatica A, Bozzoni I. Long noncoding RNAs: new players in cell differentiation and development\[J\]. Nat Rev Genet, 2014, 15(1):7-21.
[5]Esteller M. Noncoding RNAs in human disease\[J\]. Nat Rev Genet, 2011, 12(12):861-874.
[6]Tano K, Akimitsu N. Long noncoding RNAs in cancer progression\[J\]. Front Genet, 2012, 3:219.
[7]郑红艳, 李加桩, 鲍永霞, 等. lncRNA: 非小细胞肺癌诊断治疗的新策略\[J\]. 中国肿瘤, 2017, 26(4):272-278.
[8]Gibb EA, Brown CJ, Lam WL. The functional role of long noncoding RNA in human carcinomas\[J\]. Mol Cancer, 2011, 10:38.
[9]Tang J, Jiang R, Deng L, et al. Circulation long noncoding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma\[J\]. Oncotarget, 2015, 6(6):4505-4515.
[10]Arita T, Ichikawa D, Konishi H, et al. Circulating long noncoding RNAs in plasma of patients with gastric cancer\[J\]. Anticancer Res, 2013, 33(8):3185-3193.
[11]Crea F, Watahiki A, Quagliata L, et al. Identification of a long noncoding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer\[J\]. Oncotarget, 2014, 5(3):764-774.
[12]Guo F, Fang YU, Wang J, et al. Expression of MALAT1 in the peripheral whole blood of patients with lung cancer\[J\]. Biomed Rep, 2015, 3(3):309-312.
[13]Weber DG, Johnen G, Casjens S, et al. Evaluation of long noncoding RNA MALAT1 as a candidate bloodbased biomarker for the diagnosis of nonsmall cell lung cancer\[J\]. BMC Res Notes, 2013, 6:518.
[14]Li J, Li Z, Zheng W, et al. lncRNAATB: An indispensable cancerrelated long noncoding RNA\[J\]. Cell Proliferation, 2017, 47(1):95-102.
[15]Ke L, Xu SB, Wang J, et al. High expression of long noncoding RNA ATB indicates a poor prognosis and regulates cell proliferation and metastasis in nonsmall cell lung cancer\[J\]. Clin Transl Oncol, 2017, 19(5):1-7.
[16]徐丹, 李军川. 肺腺癌组织和血清中lncRNAATB表达及临床意义分析\[J\]. 临床肿瘤学杂志, 2016, 21(3):218-222.
[17]Schmidt LH, Spieker T, Koschmieder S, et al. The Long noncoding MALAT1 RNA indicates a poor prognosis in nonsmall cell lung cancer and induces migration and tumor growth\[J\]. J Thorac Oncol, 2011, 6(12):1984-1992.
[18]Kogure T, Yan IK, Lin WL, et al. Extracellular vesiclemediated transfer of a novel long noncoding RNA TUC339: A mechanism of intercellular signaling in human hepatocellular cancer\[J\]. Gene Cancer, 2013, 4(7-8):261-272.
[19]Tani H, Nakamura Y, Ijiri K, et al. Stability of MALAT1, a nuclear longcoding RNA in mammalian cells, varies in various cancer cells\[J\]. Drug Discov Ther, 2010, 4(4):235-239.
[20]Ren S, Wang F, Shen J, et al. Long noncoding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasmabased biomarker for diagnosing prostate cancer\[J\]. Eur J Cancer, 2013, 49(13):2949-2959.
[21]Lai MC, Yang Z, Zhou L, et al. Long noncoding RNA MALAT1 overexpression predicts recurrence of hepatocellular carcinoma after liver transplantion\[J\]. Med Oncol, 2012, 29(3):1810-1816. |